As the Associate Director of Business Development and Licensing at Massachusetts General Brigham (MGB) Innovation, Nina Dinjaski, PhD is responsible for formulating strategies and overseeing the commercialization of research and intellectual property derived from McLean Hospital and the Massachusetts General Hospital department of psychiatry. Prior to this position, she held the role of Associate Director of Business Development - Head of Equity Investments at Revvity (PerkinElmer), where she was managing strategic partnerships and equity investments. Before joining Revvity, Nina worked at MGB Innovation and Tufts University, Office for Technology Transfer and Industry Collaboration, overseeing diverse intellectual property portfolios. In the earlier stages of her career, Nina undertook a joint postdoctoral scholar appointment at the Department of Civil and Environmental Engineering at MIT and the Department of Biomedical Engineering at Tufts. She earned her Ph.D. in molecular microbiology from Complutense University in Spain, with a research focus on employing genetic and metabolic engineering strategies to functionalize biomaterials for medical applications.